Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000631828 | SCV000752924 | likely benign | Long QT syndrome | 2023-08-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002388012 | SCV002697711 | uncertain significance | Cardiovascular phenotype | 2022-01-04 | criteria provided, single submitter | clinical testing | The c.1033-5C>G intronic variant results from a C to G substitution 5 nucleotides upstream from coding exon 8 in the KCNQ1 gene. This nucleotide position is not well conserved in available vertebrate species. In silico splice site analysis for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Color Diagnostics, |
RCV003591763 | SCV004358404 | uncertain significance | Cardiac arrhythmia | 2022-04-19 | criteria provided, single submitter | clinical testing | This variant causes a C to G nucleotide substitution at the -5 position of intron 7 of the KCNQ1 gene. Splice prediction tools and conservation analysis are inconclusive regarding the impact of this variant on RNA splicing. To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with cardiovascular disorders in the literature. This variant has been identified in 4/282750 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |